The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tamoxifen (TAM)-induced severe hot flashes (HF): Is dose reduction (DR) a safe and effective strategy?
 
Clara Inkyung Lee
Honoraria - Roche Pharma AG
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
Peter Fox
No Relationships to Disclose
 
Bavanthi Balakrishnar
No Relationships to Disclose
 
Rosemary L Balleine
No Relationships to Disclose
 
Bo Gao
No Relationships to Disclose
 
Pamela Provan
No Relationships to Disclose
 
Sally Coulter
No Relationships to Disclose
 
Mark Tomlins
No Relationships to Disclose
 
Christopher Liddle
Stock and Other Ownership Interests - Specialist Services Group
Patents, Royalties, Other Intellectual Property - The Salk Institute; The University of Sydney
 
Rina Hui
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme
 
Mark Wong
Travel, Accommodations, Expenses - Roche Pharma AG
 
Howard Gurney
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Pfizer
Speakers' Bureau - Sanofi
 
Nicholas Wilcken
Consulting or Advisory Role - Novartis; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG